NCT02914509View on ClinicalTrials.gov

Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT

PHASE3CompletedINTERVENTIONAL
Enrollment

565

Participants

Timeline

Start Date

November 7, 2016

Primary Completion Date

March 30, 2019

Study Completion Date

March 30, 2019

Conditions
Open Angle GlaucomaOcular Hypertension
Interventions
DRUG

Travoprost

OTHER

Placebo Vehicle

Trial Locations (10)

Unknown

Artesia

Colorado Springs

Lakeland

Morrow

Shawnee Mission

Des Peres

Rochester

Raleigh

Cincinnati

Austin

Sponsors
All Listed Sponsors
lead

Ocular Therapeutix, Inc.

INDUSTRY

NCT02914509 - Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT | Biotech Hunter | Biotech Hunter